Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Aignosis ₹40M SeedCtrlS Datacenters ₹2.5B Funding roundRanked by rounds participated in, from announcements in Jul 30, 2026 – Oct 27, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Aignosis ₹40M SeedCtrlS Datacenters ₹2.5B Funding roundNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Spectronix ¥518M Series F extensionEight Knot, Inc. ¥450M Series A first closeNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Homeward $120M Series DMainstay >$18M FundingNew companies 2 · Follow-on 0
Stages: Seed 2
Satlyt $8M SeedBluecore Energy $40M Seed — additional capital within USD50m financingNew companies 2 · Follow-on 0
Stages: Undisclosed 2
DIG Ventures Fund III $120M Fund closeExein $270M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
DIG Ventures Fund III $120M Fund closeNomos €20M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
JAOPS ¥260M SeedARK Co., Ltd. ~¥1.3B Series ANew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Varda $251M Series DNscale $3.4B Pre-IPO convertible loan notesNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Cold Solutions Rwanda ≤$18M Senior debt facilitySpiro $18M Debt extensionNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
OuterSignal $22M Series AActualyze AI $7M SeedNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Inbolt €11M €11 million funding roundHighLife €80M Financing roundNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Astrocyte Pharmaceuticals Inc. $9.5M Series BRapta $8M FundingNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Simple Energy ₹17.5B Series CProdoc AI Undisclosed SeedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Varda $251M Series DRegent $240M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Metaview $60M Series CExein $270M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
Varda $251M Series DPositron AI ≤$875M Series C and Series C-1 financing packageNew companies 2 · Follow-on 0
Stages: Series B 2
AnaCardio €62.5M Series BNovaGo Therapeutics CHF 24M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Zenithon AI $10M SeedHubble Network $200M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Restate $20M Series ABasecamp Research $140M Series CNew companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
CScale $145M Series CCelero Communications $275M Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.